March 2, 2017 / 12:16 AM / 6 months ago

BRIEF-Valeant Pharmaceuticals corrects misleading report about Salix investigation

March 1 (Reuters) - Valeant Pharmaceuticals International Inc:

* Valeant Pharmaceuticals corrects misleading report about Salix investigation

* Valeant - SEC investigation into possible securities law violations by salix was first disclosed on April 30, 2015 in co's quarterly report on form 10-Q

* Valeant - investigation relates to legacy salix matters that precede acquisition of Salix by Valeant in April 2015

* Valeant-Corrected "erroneous" news report that mischaracterized timing of initiation of SEC investigation disclosed in form 10-K for year ended Dec 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below